Septic Shock Short-term Outcomes in Hospitalized Patients with Major Psychiatric Disorders: Analysis from the National Inpatient Sample Database.

[1]  L. Oud,et al.  Impact of history of mental disorders on short-term mortality among hospitalized patients with sepsis: A population-based cohort study , 2022, PloS one.

[2]  A. Dayer,et al.  Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: A narrative review , 2021, Neuroscience & Biobehavioral Reviews.

[3]  Chien-Chang Lee,et al.  Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study , 2020, PloS one.

[4]  Ameneh Zare-Shahabadi,et al.  Cytokine Alterations in Schizophrenia: An Updated Review , 2019, Front. Psychiatry.

[5]  Masaru Mimura,et al.  Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review , 2019, Psychiatry Research.

[6]  R. Howard,et al.  Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder , 2019, BMJ Open.

[7]  R. Mark,et al.  The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study , 2019, Critical Care.

[8]  Kyung Chul Shin,et al.  Repositioning of the antipsychotic drug TFP for sepsis treatment , 2019, Journal of Molecular Medicine.

[9]  A. Gaultier,et al.  Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis , 2019, Science Translational Medicine.

[10]  K. Laudanski,et al.  Factors Underlying Racial Disparities in Sepsis Management , 2018, Healthcare.

[11]  K. Reinhart,et al.  A risk-model for hospital mortality among patients with severe sepsis or septic shock based on German national administrative claims data , 2018, PloS one.

[12]  Susan Gruber,et al.  Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 , 2017, JAMA.

[13]  T. Su,et al.  Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases , 2017, Journal of Biomedical Science.

[14]  C. Holmes,et al.  Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study , 2017, Brain, Behavior, and Immunity.

[15]  John T. Menchaca,et al.  Estimating Ten‐Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data , 2017, Chest.

[16]  E. Susser,et al.  Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas , 2017, World psychiatry : official journal of the World Psychiatric Association.

[17]  K. Ressler,et al.  Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond , 2017, Neuropsychopharmacology.

[18]  D. Davydow,et al.  The association of unipolar depression with thirty-day mortality after hospitalization for infection: A population-based cohort study in Denmark. , 2016, Journal of psychosomatic research.

[19]  V. Mondelli,et al.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? , 2016, Psychopharmacology.

[20]  S. Ryter,et al.  Endoplasmic Reticulum Stress–Induced IRE1α Activation Mediates Cross-Talk of GSK-3β and XBP-1 To Regulate Inflammatory Cytokine Production , 2015, The Journal of Immunology.

[21]  W. Katon,et al.  Thirty-Day Mortality After Infection Among Persons With Severe Mental Illness: A Population-Based Cohort Study in Denmark. , 2015, The American journal of psychiatry.

[22]  J. Sundquist,et al.  Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. , 2013, JAMA psychiatry.

[23]  M. Gissler,et al.  Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden , 2013, PloS one.

[24]  T. Laursen.  Life expectancy among persons with schizophrenia or bipolar affective disorder , 2011, Schizophrenia Research.

[25]  P. Mortensen,et al.  Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. , 2009, Archives of general psychiatry.

[26]  M. Mathieu,et al.  Anti-inflammatory properties of desipramine and fluoxetine , 2007, Respiratory research.

[27]  Arise.  The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand. , 2007, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[28]  J. Lieberman,et al.  Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline , 2006, Schizophrenia Research.

[29]  L. Miteva,et al.  High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors , 2005, Intensive Care Medicine.

[30]  N. Takeyama,et al.  Effect of interferon gamma on sepsis-related death in patients with immunoparalysis , 2004, Critical Care.

[31]  T. Standiford,et al.  Sepsis-induced immunosuppression , 2001, Immunologic research.

[32]  B. Druss,et al.  Mental disorders and use of cardiovascular procedures after myocardial infarction. , 2000, JAMA.

[33]  J. Dipiro,et al.  Association of interleukin-4 plasma levels with traumatic injury and clinical course. , 1995, Archives of surgery.